Healthcare provider profile · identity verified

Konstantin Alekseyenko, DO

Family Practice · PORT ST LUCIE, FL · NPI 1164801130

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	168
Rosuvastatin Calcium	Rosuvastatin Calcium	517	168
Amlodipine Besylate	Amlodipine Besylate	384	121
Levothyroxine Sodium	Levothyroxine Sodium	339	99
Metformin Hcl	Metformin Hcl	292	93
Losartan Potassium	Losartan Potassium	286	99
Lisinopril	Lisinopril	233	73
Omeprazole	Omeprazole	226	77
Tamsulosin Hcl	Tamsulosin Hcl	220	76
Metoprolol Succinate	Metoprolol Succinate	208	72
Simvastatin	Simvastatin	200	58
Gabapentin	Gabapentin	179	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	151	47
Trazodone Hcl	Trazodone Hcl	145	44
Famotidine	Famotidine	139	55
Pantoprazole Sodium	Pantoprazole Sodium	139	50
Hydrochlorothiazide	Hydrochlorothiazide	118	48
Citalopram Hbr	Citalopram Hydrobromide	105	36
Pravastatin Sodium	Pravastatin Sodium	105	34
Fluoxetine Hcl	Fluoxetine Hcl	101	30
Metoprolol Tartrate	Metoprolol Tartrate	100	31
Fluticasone Propionate	Fluticasone Propionate	96	35
Allopurinol	Allopurinol	88	30
Metformin Hcl Er	Metformin Hcl	74	25
Glipizide	Glipizide	72	23
Montelukast Sodium	Montelukast Sodium	70	23
Sertraline Hcl	Sertraline Hcl	69	24
Furosemide	Furosemide	64	25
Synthroid	Levothyroxine Sodium	63	19
Clopidogrel	Clopidogrel Bisulfate	60	20
Finasteride	Finasteride	60	21
Ezetimibe	Ezetimibe	59	22
Albuterol Sulfate Hfa	Albuterol Sulfate	58	30
Meloxicam	Meloxicam	56	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Eliquis	Apixaban	53	17
Valsartan	Valsartan	50	21
Atenolol	Atenolol	48	16
Escitalopram Oxalate	Escitalopram Oxalate	47	16
Alprazolam	Alprazolam	44	31
Potassium Chloride	Potassium Chloride	43	18
Azithromycin	Azithromycin	42	37
Carvedilol	Carvedilol	41	13
Olmesartan Medoxomil	Olmesartan Medoxomil	39	suppressed
Ozempic	Semaglutide	39	11
Doxazosin Mesylate	Doxazosin Mesylate	38	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	38	12
Duloxetine Hcl	Duloxetine Hcl	36	13
Ipratropium Bromide	Ipratropium Bromide	35	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	12
Ramipril	Ramipril	35	suppressed
Glimepiride	Glimepiride	34	13
Xarelto	Rivaroxaban	34	13
Doxepin Hcl	Doxepin Hcl	33	18
Valacyclovir	Valacyclovir Hcl	32	16
Buspirone Hcl	Buspirone Hcl	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Celecoxib	Celecoxib	28	11
Glipizide Er	Glipizide	27	suppressed
Methylprednisolone	Methylprednisolone	26	26
Pregabalin	Pregabalin	26	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Cephalexin	Cephalexin	22	19
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Belsomra	Suvorexant	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Testosterone	Testosterone	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Chlorthalidone	Chlorthalidone	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	11
Benazepril Hcl	Benazepril Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error